PASITHEA THERAPEUTICS CORP (KTTA) Stock Income Statement
NASDAQ:KTTA - Nasdaq - US70261F2020 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 15.10K | 0.00 | |||
| Cost Of Goods | N/A | 110.00K | 17.30K | N/A | |||
| Gross Profit | N/A | 370.00K | -2.20K | N/A | |||
| Operating Expenses | 15.98M | 12.59M | 4.51M | 41.00K | |||
| Research and Development | 8.10M | 2.67M | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 7.88M | 9.92M | 4.51M | 41.00K | |||
| Operating Income | -15.98M | -12.59M | -4.51M | -41.00K | |||
| Interest Income/Expense | 415.40K | 0.00 | -500.00 | N/A | |||
| Other Income/Expense | 56.30K | 1.86M | 2.33M | N/A | |||
| Non Recurring Items | 0.00 | -1.00M | N/A | N/A | |||
| Income Before Taxes | -15.51M | -11.73M | -2.17M | -41.00K | |||
| Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -15.96M | -13.94M | -2.17M | -41.00K | |||
| EBITDA | -15.33M | -12.58M | -4.51M | N/A | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -13.01 | -11.04 | -1.89 | -0.06 | |||
| Statistics | |||||||
| Gross Profit Margin | N/A | N/A | -14.57% | N/A | |||
| Profit Margin | N/A | N/A | -14394.04% | N/A | |||
| Operating Profit Margin | N/A | N/A | -29850.33% | N/A | |||
All data in USD